Position in PFE
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$94,581,273
+$9,424,494 QoQ
Shares Held
3,368,279
-1.5% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026DANSKE BANK A/S holds $2,170,128,870 across 11 Drug Manufacturers - General names. PFE ranks #7 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
760,386 | $699,380,229 | |
| 2 | JNJ |
Johnson & Johnson
|
2,072,836 | $506,684,030 | |
| 3 | ABBV |
AbbVie Inc.
|
1,320,250 | $287,141,170 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,779,179 | $214,017,440 | |
| 5 | AMGN |
Amgen Inc
|
433,304 | $152,458,010 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
857,393 | $119,494,861 | |
| 7 | PFE |
Pfizer Inc
This page
|
3,368,279 | $94,581,273 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,445,624 | $87,677,094 |
All Filings in PFE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $94,581,273 | 3,368,279 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $85,156,779 | 3,419,951 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $81,297,684 | 3,190,647 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $102,683,668 | 4,236,125 | Shares | Sole | 2025-12-18 | |
| 2025-03-31 | $93,743,073 | 3,699,411 | Shares | Sole | 2025-12-18 | |
| 2024-12-31 | $85,003,259 | 3,204,043 | Shares | Sole | 2026-03-18 | |
| 2024-09-30 | $107,623,315 | 3,718,843 | Shares | Sole | 2026-03-18 | |
| 2024-06-30 | $77,628,551 | 2,774,430 | Shares | Sole | 2026-03-18 | |
| 2024-03-31 | $74,392,977 | 2,680,828 | Shares | Sole | 2026-03-18 | |
| No filing history on record for this holder in this stock. | ||||||